MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5

C.-M. Sun, G.-M. Zhang, H.-N. Qian, S.-J. Cheng, M. Wang, M. Liu, D. Li

Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

---

• Oncology

The article “MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5, by C.-M. Sun, G.-M. Zhang, H.-N. Qian, S.-J. Cheng, M. Wang, M. Liu, D. Li, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6436-6444–PMID: 31378882” has been withdrawn from the authors due to some inaccuracies (some data cannot be repeated by our further research).

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/18525

Free PDF Download